Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2015
Half-sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cellsMaria V Babak, Damian Plażuk, Samuel M Meier, et al.
Molecular & Cellular Proteomics : MCP|December 3, 2017
Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemiaRupert L Mayer, Josef D Schwarzmeier, Marlene C Gerner, et al.
Pharmaceutics|February 26, 2022
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose DeprivationDina Baier, Beatrix Schoenhacker-Alte, Mate Rusz, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Molecular Nutrition & Food Research|December 25, 2016
A 12-week intervention with nonivamide, a TRPV1 agonist, prevents a dietary-induced body fat gain and increases peripheral serotonin in moderately overweight subjectsChristina M Hochkogler, Barbara Lieder, Petra Rust, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 12, 2015
Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative ActivityPaul-Steffen Kuhn, Laura Cremer, Anatolie Gavriluta, et al.
Journal of Medicinal Chemistry|January 27, 2026
Structure-Activity Relationships of Silver(I)- and Gold(I)-NHC Complexes Reveal Distinctly Different Responses of Cisplatin-Resistant Ovarian Cancer to Bis-NHC-Gold(I) DerivativesJulia H Bormio Nunes, Christina Hacker, Monika Caban, et al.
Chempluschem|January 22, 2020
Functionalization of Ruthenium(II)(η<sup>6</sup> -p-cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical StudiesMuhammad Hanif, Samuel M Meier, Zenita Adhireksan, et al.
Iscience|December 12, 2022
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndromeJohannes J Kovarik, Andrea Bileck, Gerhard Hagn, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 27, 2023
The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone AcetylationDina Baier, Theresa Mendrina, Beatrix Schoenhacker-Alte, et al.
Pageof 9